DCTH (Delcath Systems) Cyclically Adjusted PB Ratio: (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DCTH Delcath Systems Inc DCTH
77 GF Score
Price $16.45
GF Value $29.56
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Delcath Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Delcath Systems  (NAS:DCTH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Delcath Systems Cyclically Adjusted PB Ratio Related Terms


Delcath Systems Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Delcath Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delcath Systems Cyclically Adjusted PB Ratio Chart

Delcath Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Delcath Systems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DCTH vs CERS, CTKB, TCMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Delcath Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delcath Systems Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Cyclically Adjusted PB Ratio falls into.


DCTH
77GF Score
Delcath Systems Inc DCTH
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delcath Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Delcath Systems's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Delcath Systems's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.498/333.9520*333.9520
=3.498

Current CPI (Jun. 2026) = 333.9520.

Delcath Systems Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 -925.000 246.819 -1,251.547
201712 339.000 246.524 459.224
201803 -6,202.000 249.554 -8,299.488
201806 -13,090.000 251.989 -17,347.708
201809 -608.125 252.439 -804.490
201812 -995.933 251.233 -1,323.846
201903 -1,132.238 254.202 -1,487.451
201906 -1,143.423 256.143 -1,490.763
201909 -724.038 256.759 -941.716
201912 -94.881 256.974 -123.303
202003 -109.658 258.115 -141.877
202006 2.187 257.797 2.833
202009 0.812 260.280 1.042
202012 3.682 260.474 4.721
202103 3.200 264.877 4.035
202106 2.062 271.696 2.534
202109 1.594 274.310 1.941
202112 1.512 278.802 1.811
202203 0.661 287.504 0.768
202206 -0.360 296.311 -0.406
202209 -0.610 296.808 -0.686
202212 -0.583 296.797 -0.656
202303 -1.297 301.836 -1.435
202306 -0.016 305.109 -0.018
202309 1.255 307.789 1.362
202312 0.693 306.746 0.754
202403 0.575 312.332 0.615
202406 0.150 314.175 0.159
202409 0.306 315.301 0.324
202412 2.079 315.605 2.200
202503 2.399 319.799 2.505
202506 3.003 322.561 3.109
202509 3.253 324.800 3.345
202512 3.206 324.054 3.304
202603 3.270 330.213 3.307
202606 3.498 333.952 3.498

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Delcath Systems (DCTH) Overvalued in 2026?

Based on GuruFocus' analysis, Delcath Systems stock appears to be undervalued. The current stock price of $16.45 is trading 44.4% below its estimated GF Value™ of $29.56. GuruFocus considers Delcath Systems to be Significantly Undervalued.

Key valuation signals for DCTH:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $29.56 vs. price of $16.45 (44.4% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the DCTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Delcath Systems Business Description

Other Exchanges DV3R:Germany
Address 566 Queensbury Avenue, Queensbury, NY, USA, 12804
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
77GF Score

Get the complete analysis for DCTH

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.45
Price
$29.56
GF Value